Change of Treatment Landscape and Survival in Metastatic Pancreatic Cancer After Nal-IRI in Republic of Korea

NCT05587387 · clinicaltrials.gov ↗
UNKNOWN
Status
250
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Yonsei University